Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Vitamin C intake and the risk of gout in men: a prospective study.

Choi HK, Gao X, Curhan G.

Arch Intern Med. 2009 Mar 9;169(5):502-7. doi: 10.1001/archinternmed.2008.606.

2.

Uric acid and cardiovascular risk.

Feig DI, Kang DH, Johnson RJ.

N Engl J Med. 2008 Oct 23;359(17):1811-21. doi: 10.1056/NEJMra0800885. Review. No abstract available. Erratum in: N Engl J Med. 2010 Jun 10;362(23):2235.

3.
4.

A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout.

Reinders MK, Haagsma C, Jansen TL, van Roon EN, Delsing J, van de Laar MA, Brouwers JR.

Ann Rheum Dis. 2009 Jun;68(6):892-7. doi: 10.1136/ard.2008.091462. Epub 2008 Jul 16.

PMID:
18633127
5.

Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial.

Janssens HJ, Janssen M, van de Lisdonk EH, van Riel PL, van Weel C.

Lancet. 2008 May 31;371(9627):1854-60. doi: 10.1016/S0140-6736(08)60799-0.

PMID:
18514729
6.

Long-term cardiovascular mortality among middle-aged men with gout.

Krishnan E, Svendsen K, Neaton JD, Grandits G, Kuller LH; MRFIT Research Group.

Arch Intern Med. 2008 May 26;168(10):1104-10. doi: 10.1001/archinte.168.10.1104.

PMID:
18504339
7.

Systemic corticosteroids for acute gout.

Janssens HJ, Lucassen PL, Van de Laar FA, Janssen M, Van de Lisdonk EH.

Cochrane Database Syst Rev. 2008 Apr 16;(2):CD005521. doi: 10.1002/14651858.CD005521.pub2. Review.

PMID:
18425920
8.

Management of recurrent gout.

Fox R.

BMJ. 2008 Feb 9;336(7639):329. doi: 10.1136/bmj.39273.712674.94. Review. No abstract available.

9.

Sugary drinks, fruit, and increased risk of gout.

Underwood M.

BMJ. 2008 Feb 9;336(7639):285-6. doi: 10.1136/bmj.39479.667731.80. No abstract available.

10.

Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol.

Reinders MK, van Roon EN, Jansen TL, Delsing J, Griep EN, Hoekstra M, van de Laar MA, Brouwers JR.

Ann Rheum Dis. 2009 Jan;68(1):51-6. doi: 10.1136/ard.2007.083071. Epub 2008 Feb 4.

PMID:
18250112
11.

Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study.

Choi HK, Curhan G.

BMJ. 2008 Feb 9;336(7639):309-12. doi: 10.1136/bmj.39449.819271.BE. Epub 2008 Jan 31.

12.

Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 Austrian men.

Strasak A, Ruttmann E, Brant L, Kelleher C, Klenk J, Concin H, Diem G, Pfeiffer K, Ulmer H; VHM&PP Study Group.

Clin Chem. 2008 Feb;54(2):273-84. Epub 2007 Nov 26.

13.

Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel.

Halevy S, Ghislain PD, Mockenhaupt M, Fagot JP, Bouwes Bavinck JN, Sidoroff A, Naldi L, Dunant A, Viboud C, Roujeau JC; EuroSCAR Study Group.

J Am Acad Dermatol. 2008 Jan;58(1):25-32. Epub 2007 Oct 24.

PMID:
17919772
14.

Gout: an update.

Eggebeen AT.

Am Fam Physician. 2007 Sep 15;76(6):801-8. Review.

16.

British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout.

Jordan KM, Cameron JS, Snaith M, Zhang W, Doherty M, Seckl J, Hingorani A, Jaques R, Nuki G; British Society for Rheumatology and British Health Professionals in Rheumatology Standards, Guidelines and Audit Working Group (SGAWG).

Rheumatology (Oxford). 2007 Aug;46(8):1372-4. Epub 2007 May 23. No abstract available.

PMID:
17522099
17.

Lumiracoxib 400 mg once daily is comparable to indomethacin 50 mg three times daily for the treatment of acute flares of gout.

Willburger RE, Mysler E, Derbot J, Jung T, Thurston H, Kreiss A, Litschig S, Krammer G, Tate GA.

Rheumatology (Oxford). 2007 Jul;46(7):1126-32. Epub 2007 May 3.

PMID:
17478464
18.

NSAID use and progression of chronic kidney disease.

Gooch K, Culleton BF, Manns BJ, Zhang J, Alfonso H, Tonelli M, Frank C, Klarenbach S, Hemmelgarn BR.

Am J Med. 2007 Mar;120(3):280.e1-7.

PMID:
17349452
20.

Supplemental Content

Support Center